ExploreWatchlistsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Working capital

KYORIN Pharmaceutical Co., Ltd. (4569)

Market cap
¥69.9B
P/E ratio
44.7x
Kyorin Pharmaceutical manufactures and sells pharmaceutical products through an integrated system spanning from production to sales across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndWorking capital (Million JPY)YoY (%)
Mar 31, 202153,006-4.64%
Mar 31, 202055,586+2.71%
Mar 31, 201954,118+9.67%
Mar 31, 201849,345+2.94%
Mar 31, 201747,936-6.58%
Mar 31, 201651,312+3.42%
Mar 31, 201549,616

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat